Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. has announced that their Board of Directors will convene on Wednesday, October 23, 2024, to review and approve the unaudited quarterly financial results for the nine months ending September 30, 2024. This meeting will also address other business matters. The announcement was made by the company secretary, Yang Liang, and includes a list of the current executive and non-executive directors.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
